USA-based CritiTech and privately-held Indian group Finoso Pharma have formally established a joint venture which will be named Finotech Pharma with a business 16 July 2012
Agila Specialties Pharma Canada, which is part of the injectable drug division of Indian generic drugmaker Strides Arcolab (BO: 532531), has formed a joint vent 16 July 2012
UK pharma giant GlaxoSmithKline (LSE: GSK) revealed yesterday that it has withdrawn a supplemental New Drug Application to the US Food and Drug Administration f 13 July 2012
US drugs giant Merck & Co has begun talks with privately-held Indian drugmaker Micro Labs to acquire the maker of active pharmaceutical ingredients (APIs) and f 22 June 2012
US pharma major Eli Lilly (NYSE: LLY) says it will increase of its network of manufacturing capabilities in the key emerging market of China through an expanded 13 June 2012
Belgium's leading pharma company UCB (Euronext Brussels: UCB) says it has signed an agreement to acquire a 51% stake in Meizler Biopharma, a privately-owned Bra 31 May 2012
Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, revealed this morning that it has entered into an agreeement to acquire the Brazilian compony Mult 25 May 2012
Privately-held US aesthetics company Suneva Medical has acquired an aesthetic product portfolio from Spear Pharmaceuticals. Under the terms of the agreement, Su 24 May 2012
Further expanding its generic drug foot print, Swiss drug giant Novartis (NOVN: VX) is adding to its franchise with a definitive agreement to acquire Melville, 3 May 2012
Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world's largest generics companies, said yesterday that it has settled patent infringement litig 1 May 2012
The economic recession has been a double-edged sword for the international generic drugs business. Driven by the need to control costs, the use of generic drugs 29 April 2012
US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings, including the 'BBB' Issuer Default Rating (IDR), on Ra 26 April 2012
As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive agreement to acquire privately-owned generics firm Act 26 April 2012
Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an agreement to acquire certain assets from Atlantis Pharma, 19 April 2012
USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics to expand the company's buffer pr 16 April 2012
Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals (NYSE: WPI) for as much as 5.5 billion euros ($7.3 b 22 March 2012
Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired Eclat Pharmaceuticals, a US specialty pharmaceutica 19 March 2012
The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 18 March 2012
Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an agreement to buy certain assets from Gerot Lannach, a bran 14 March 2012
Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading Chinese manufacturers of active pharmaceutical ingredie 19 February 2012
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news